Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based ...
foodengineeringmag11h
Forsea Reports Cell Density Increase for Cell-Cultivated Eel
Forsea has created a new approach to cell cultivating fish tissues outside of their native water habitats via organoid ...
Business Insider20h
Invizyne Technologies Begins Trading on NASDAQ
Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing ... date subsequent to the date of this press release. Media ...
Business Wire1d
SoftBank Corp. Develops 5G L1 Software, Achieving Carrier-grade High Performance and Quality vRAN on NVIDIA Grace Hopper Platform
SoftBank conducts world’s first outdoor test with 20 5G cells on a single server featuring the NVIDIA GH200 Grace Hopper ...
TMCnet1d
Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Initiated the Phase 2 MoonStone trial, a Phase 2, multicenter, randomized, double-blind, placebo-controlled trial, to evaluate the efficacy and safety of obexelimab in patients with Relapsing Multiple ...
Assembly Mag2d
Suniva Resumes U.S. Solar Cell Production in Georgia
Suniva's move aligns with President Biden's efforts to strengthen U.S. solar production and reduce dependence on China. The company has started producing commercial solar cells and is fulfilling a ...